Ro
Ro (Roman Health Ventures) is a direct-to-consumer telehealth company offering treatments for men's and women's health, weight loss (including GLP-1s), fertility and dermatology through subsidiaries Roman, Rory, Zero and Modern Fertility. Founded in 2017 and headquartered in New York, Ro has raised approximately $1B at a $7B valuation, most recently in a 2022 Series D.
Company snapshot
- Active
- Total funding
- $1.0B
- Funding rounds
- 7
- Last round (Series D)
- $150M
- Last round date
- Mar 2022
- Founded
- 2017
- Employees
- 501-1000
- Headquarters
- New York, New York, United States
Founders
Zachariah Reitano, Saman Rahmanian, Rob Schutz
Industries
- Telehealth
- Healthcare
- Direct-to-Consumer
- Digital Health
Notable investors
| Investor | Role |
|---|---|
| General Catalyst | Lead |
| FirstMark Capital | Lead |
| TQ Ventures | Co-investor |
| ShawSpring Partners | Lead |
| Initialized Capital | Co-investor |
| BoxGroup | Co-investor |
Frequently asked questions
How much funding has Ro raised?
Ro has raised $1.0B in total funding across 7 rounds.
What was Ro's most recent funding round?
Ro's most recent round was a Series D of $150M in Mar 2022.
When was Ro founded?
Ro was founded in 2017.
Where is Ro headquartered?
Ro is headquartered in New York, New York, United States.
How many employees does Ro have?
Ro has 501-1000 employees.
Who are Ro's investors?
Ro's notable investors include General Catalyst, FirstMark Capital, TQ Ventures, ShawSpring Partners, Initialized Capital, BoxGroup.